LUXRX
DEAD

Serial Number

98043421

Owner

Davidson, Daniel Shane Sheibani

First Use Date

Mar 1, 2020

Filing Date

Jun 15, 2023

Add to watchlist:

No watchlists yet
View on USPTO

LUXRX Trademark

Serial Number: 98043421

LUXRX is a trademark filed by Davidson, Daniel Shane Sheibani on June 15, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Davidson, Daniel Shane Sheibani (9 trademarks)

330 W. Olive St.
Inglewood, CA 90301

Entity Type: 01

Trademark Details

Filing Date

June 15, 2023

Registration Date

Not Registered

First Use Anywhere

March 1, 2020

First Use in Commerce

June 14, 2023

Goods & Services

Medicated liquid soaps; Medicated balms for treatment of skin care, pain management, discomfort, ache, muscle and joint; Medicated candies; Medicated candy; Medicated chewing gum; Medicated compresses; Medicated cosmetics; Medicated creams for treating dermatological conditions; Medicated dermatological preparations and substances; Medicated diaper rash cream; Medicated diaper rash lotions; Medicated diaper rash ointment; Medicated diaper rash ointments and lotions; Medicated facial cleansers; Medicated foot bath preparations; Medicated grooming preparations for hair care, skin care, etc., namely, hair loss and skin complexion; Medicated lotions for sunburn; Medicated lotions for treating dermatological conditions; Medicated lotions for skin care, pain management, discomfort, ache, muscle and joint; Medicated lozenges; Medicated make-up; Medicated massage oils; Medicated moisturizers; Medicated mouthwash; Medicated mouthwash for treating gingivitis; Medicated oils containing cannabis, herbs, hemp, extracts, vitamins; Medicated ointments for treating dermatological conditions; Medicated pre-moistened tissues; Medicated serums for treatment of skin care, pain management, discomfort, ache, muscle and joint; Medicated shampoo; Medicated shampoos; Medicated skin care preparations; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicated skin preparation for use in treating pain, discomfort, muscle ache; Medicated skin soap; Medicated skin toners; Medicated soap; Medicated soap for foot perspiration; Medicated sun block; Medicated sun screen; Medicated sunburn lotions; Medicated sunburn ointments; Medicated sunscreen; Medicated sweets; Medicated toothpaste; Medicated topical solution that increases the efficacy and percutaneous absorption of benzoyl peroxide; Medicated wart removing preparations; Syrups for pharmaceutical purposes for the treatment of coug, itc.h, cold, pain, discomfort; Acne medications; Allergy medication; Allergy medications; Allergy relief medication; Ampoules sold filled with medicated serums for treatment of dermatological conditions; Burn relief medication; Candy, medicated; Cough syrups; Cough syrups for medical use; Diarrhea medication; Fungal medications; Medicinal syrups containing each or all of the following in various combinations: cannibis and hemp extract, herbs, vitamins, medications for the treatment of any condition including but not limited to cough, cold, ache and pain, skin conditions and etc.; Medicinal syrups for the treatment of skin conditions, aches and pains; Multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; Non-medicated topical gel for the prevention and treatment of allergies; Non-medicated topical gel for the prevention and treatment of cold and flu; Non-medicated, therapeutic skin creams for the treatment of skin care, pain management, discomfort, ache, muscle and joint; Nutritional supplements in the form of syrups, pills, capsules, ointments, creams, etc.; Pain relief medication; Plant and herb extracts sold as components of medicated cosmetics; Stimulatory medications for use in weight reduction programs; Transdermal patches featuring cannabis and hemp extract with or without other ingredients, including medications, herbs and vitamins; Veterinary preparations, namely, pain relief medication

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jul 26, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 26, 2025 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 27, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 27, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 27, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 25, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 19, 2023 NWOS
NEW APPLICATION ENTERED
Jun 19, 2023 NWAP